NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
Details
- Buyer
- NHS England
- Supplier(s)
20 suppliers
- Abbvie Ltd
- Accord UK Ltd
- Alexion Pharmaceuticals
- Amgen Ltd
- Celltrion Healthcare United Kingdom Ltd
- CuraTeQ Biologics s.r.o.
- Dr Reddy's Laboratories (UK) Ltd
- FRESENIUS KABI LIMITED
- GLAXOSMITHKLINE UK LIMITED
- Janssen Cilag Ltd
- Organon Pharmaceuticals UK Ltd
- Orifarm UK
- Pfizer Liimted
- Roche Products Ltd
- Samsung Bioepis UK Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- Thornton and Ross
- Zentiva Pharma UK Ltd
- Value
- GBP 24
- Topic
- Pharmaceutical products
- Published
- 29 July 2025
- Source
- uk:find_a_tender
Tender description
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 Lot 1: Lot 1 - CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents. Lot 2: Lot 2 - CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE Eculizumab and Ravulizumab for London & SOFE. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
Timeline
- Completed: Award date1 July 2025
- Completed: Award published29 July 2025Current notice
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 353£15.0bn
- 293£2.8bn
- 261£19.7bn
- 252£892.4m
- 243£509.0m
- 203£1.0bn
- 140£895.5m
- 114£59.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
